The goal of Project ACHIEVE is to find ways to prevent HIV infection and other sexually transmitted diseases in New York City and in the United States. Project ACHIEVE, established in 1993, is part of the New York Blood Center's Laboratory of Infectious Disease Prevention and is under the leadership of Beryl Koblin, PhD. We conduct intervention trials to develop and test innovative ways to help participants reduce the risk of HIV infection and studies spanning all phases of HIV vaccine research as part of an international effort to find a preventive HIV vaccine.
In addition to our research, we continue to educate the community to build awareness of the need for an HIV vaccine and other prevention interventions; to build acceptance and support for research; and to encourage advocacy for new trials and research. We achieve this through a variety of ways which include group presentations and workshops, conferences, and newsletters.
Some of our trial participants and other volunteers from the community form the Project ACHIEVE community advisory board (CAB). The CAB meets throughout the year to discuss the interests and concerns of target communities for HIV prevention.
Project ACHIEVE and Columbia University Medical Center work together to conduct phase 1, 2, and 3 trials of candidate preventive HIV vaccines. We also partner with other research groups and community organizations to develop and test innovative behavioral interventions.
Project ACHIEVE staff are frequently found in the streets recruiting participants for new studies and distributing HIV prevention materials. We organize and participate in community events to commemorate special days of the year such as World AIDS Day, HIV Vaccine Awareness Day, and New York City Gay Pride. These events are important to the work of Project ACHIEVE and we eagerly seek other partners who wish to support HIV prevention efforts in New York City.